Name | Sarpogrelate Hydrochloride |
Synonyms | Anplag ANPLAG MCI9042 MCI 9042 MCI-9042 Sarpogrelate HCL Sarpogrelate.HCl Sarpogrelate-D3 HCl Sarpogrelate Hydrochloride Sarpogrelate Hydrochloride intermediate Butanedioic acid, mono[2-(dimethylamino)-1-[[ 4-((1-(dimethylamino)-3-(2-(3-methoxyphenethyl)phenoxy)propan-2-yl)oxy)-4-oxobutanoic acid hydrochloride Butanedioic acid, mono[2-(dimethylamino)-1-[[2-[2-(3-methoxyphenyl)ethyl]phenoxy]methyl]ethyl] ester, hydrochloride (9CI) Butanedioic acid, mono[2-(dimethylamino)-1-[[2-[2-(3-methoxyphenyl)ethyl]phenoxy]methyl]ethyl] ester, hydrochloride, (+-)- |
CAS | 135159-51-2 |
EINECS | 663-199-9 |
InChI | InChI=1/C24H31NO6.ClH/c1-25(2)16-21(31-24(28)14-13-23(26)27)17-30-22-10-5-4-8-19(22)12-11-18-7-6-9-20(15-18)29-3;/h4-10,15,21H,11-14,16-17H2,1-3H3,(H,26,27);1H |
InChIKey | POQBIDFFYCYHOB-UHFFFAOYSA-N |
Molecular Formula | C24H32ClNO6 |
Molar Mass | 465.96698 |
Melting Point | 145-148°C |
Boling Point | 585.9°C at 760 mmHg |
Flash Point | 308.1°C |
Solubility | deionized water: ≥5mg/mL |
Vapor Presure | 1.43E-14mmHg at 25°C |
Appearance | solid |
Storage Condition | Inert atmosphere,2-8°C |
MDL | MFCD00887582 |
In vitro study | Sarpogrelate is selective for 5-HT 2 (pK i =7.54) over 5-HT 1 (pK i =4.58), α 1 -, α 2 -, and β-adrenergic (pK i =3.17-6.19), and muscarinic receptors (pK i =4.39). Sarpogrelate (10 μM) significantly reduces the number of platelet-rich plasma (PRP)-induced THP-1 cell that adheres to human umbilical vein endothelial cells (HUVECs). Sarpogrelate (10 μM) significantly reduces the expression of PRP-induced E-selectin in HUVECs. |
Risk Codes | R22 - Harmful if swallowed R50/53 - Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment. |
Safety Description | S60 - This material and its container must be disposed of as hazardous waste. S61 - Avoid release to the environment. Refer to special instructions / safety data sheets. |
UN IDs | UN 3077 9 / PGIII |
WGK Germany | 3 |